Megakaryocyte growth and development factor-induced proliferation and differentiation are regulated by the mitogen-activated protein kinase pathway in primitive cord blood hematopoietic progenitors
- PMID: 10477685
Megakaryocyte growth and development factor-induced proliferation and differentiation are regulated by the mitogen-activated protein kinase pathway in primitive cord blood hematopoietic progenitors
Abstract
In several erythroleukemia cell lines, activation of mitogen-activated protein kinases (MAPK) by phorbol esters or megakaryocyte growth and development factor (MGDF) is required for induction of megakaryocytic phenotype and growth arrest. To support this model, we have examined the effect of a specific inhibitor of this pathway (PD98059) on human CD34(+) hematopoietic progenitors isolated from cord blood (CB), induced to differentiate along the megakaryocytic lineage in liquid cultures supplemented with rhuMGDF. RhuMGDF induced a sustained activation of MAPK in megakaryocytes and this activation was completely inhibited in the presence of low concentrations of PD98059 (6 to 10 micromol/L). At this concentration, PD98059 induced an increase in cell proliferation, resulting in accumulation of viable cells and a prolongation of the life time of the cultures. This increase correlated with an increase in DNA synthesis rather than with a reduction in apoptosis. This effect was combined with developmental changes indicative of delayed megakaryocytic differentiation: (1) PD98059-treated cells tended to retain markers of immature progenitors as shown by the increased proportion of both CD34(+) and CD41(+)CD34(+) cells. (2) PD98059-treated cultures were greatly enriched in immature blasts cells. (3) PD98059 increased megakaryocytic progenitors able to form colonies in semisolid assays. Thus, the MAPK pathway, although not required for megakaryocyte formation, seems to be involved in the transition from proliferation to maturation in megakaryocytes. Inhibition of MAPK activation also led to an increase in the number and size of erythroid colonies without affecting granulocyte/macrophage progenitor numbers suggesting that, in addition to the megakaryocytic lineage, the MAPK pathway could play a role in erythroid lineage differentiation.
Similar articles
-
Ex vivo expansion of megakaryocyte progenitors: effect of various growth factor combinations on CD34+ progenitor cells from bone marrow and G-CSF-mobilized peripheral blood.Exp Hematol. 1997 Oct;25(11):1125-39. Exp Hematol. 1997. PMID: 9328449
-
Proliferative properties of human umbilical cord blood megakaryocyte progenitor cells to human thrombopoietin.Exp Hematol. 1998 Mar;26(3):228-35. Exp Hematol. 1998. PMID: 9502619
-
Requirement of thrombopoietin-induced activation of ERK for megakaryocyte differentiation and of p38 for erythroid differentiation.Ann Hematol. 2001 May;80(5):284-91. doi: 10.1007/s002770000285. Ann Hematol. 2001. PMID: 11446731
-
Simultaneous signalling through c-mpl, c-kit and CXCR4 enhances the proliferation and differentiation of human megakaryocyte progenitors: possible roles of the PI3-K, PKC and MAPK pathways.Br J Haematol. 2001 Oct;115(1):175-85. doi: 10.1046/j.1365-2141.2001.03068.x. Br J Haematol. 2001. PMID: 11722431
-
Differential maturation of megakaryocyte progenitor cells from cord blood and mobilized peripheral blood.Exp Hematol. 2003 Apr;31(4):324-30. doi: 10.1016/s0301-472x(03)00004-3. Exp Hematol. 2003. PMID: 12691920
Cited by
-
A Novel Antithrombocytopenia Agent, Rhizoma cibotii, Promotes Megakaryopoiesis and Thrombopoiesis through the PI3K/AKT, MEK/ERK, and JAK2/STAT3 Signaling Pathways.Int J Mol Sci. 2022 Nov 14;23(22):14060. doi: 10.3390/ijms232214060. Int J Mol Sci. 2022. PMID: 36430539 Free PMC article.
-
A novel signalling screen demonstrates that CALR mutations activate essential MAPK signalling and facilitate megakaryocyte differentiation.Leukemia. 2017 Apr;31(4):934-944. doi: 10.1038/leu.2016.280. Epub 2016 Oct 14. Leukemia. 2017. PMID: 27740635 Free PMC article.
-
Therapeutic targeting of the MEK/MAPK signal transduction module in acute myeloid leukemia.J Clin Invest. 2001 Sep;108(6):851-9. doi: 10.1172/JCI12807. J Clin Invest. 2001. PMID: 11560954 Free PMC article.
-
Protein-arginine methyltransferase 1 suppresses megakaryocytic differentiation via modulation of the p38 MAPK pathway in K562 cells.J Biol Chem. 2010 Jul 2;285(27):20595-606. doi: 10.1074/jbc.M109.092411. Epub 2010 May 4. J Biol Chem. 2010. PMID: 20442406 Free PMC article.
-
Multiple roles of Rap1 in hematopoietic cells: complementary versus antagonistic functions.Blood. 2005 Nov 1;106(9):2952-61. doi: 10.1182/blood-2005-03-1062. Epub 2005 Aug 2. Blood. 2005. PMID: 16076873 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical